|
US20040214807A1
(en)
*
|
1993-08-06 |
2004-10-28 |
D'amato Robert J. |
Estrogenic compounds as anti-mitotic agents
|
|
US5504074A
(en)
*
|
1993-08-06 |
1996-04-02 |
Children's Medical Center Corporation |
Estrogenic compounds as anti-angiogenic agents
|
|
US6346510B1
(en)
|
1995-10-23 |
2002-02-12 |
The Children's Medical Center Corporation |
Therapeutic antiangiogenic endostatin compositions
|
|
US20030064949A1
(en)
*
|
1998-02-17 |
2003-04-03 |
Loretta Nielsen |
Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
|
|
US20030060434A1
(en)
*
|
1997-02-18 |
2003-03-27 |
Loretta Nielsen |
Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
|
|
AU1290700A
(en)
*
|
1998-12-02 |
2000-06-19 |
Pfizer Products Inc. |
Methods and compositions for restoring conformational stability of a protein of the p53 family
|
|
US6548541B1
(en)
*
|
1999-04-21 |
2003-04-15 |
Unitech Pharmaceuticals, Inc. |
Carboplatin analogs for cancer treatment
|
|
AU5010500A
(en)
*
|
1999-05-12 |
2000-11-21 |
Mayo Foundation For Medical Education And Research |
Treatment of bone cancer
|
|
US6730665B1
(en)
|
1999-05-12 |
2004-05-04 |
Mayo Foundation For Medical Education And Research |
Treatment of bone cancer
|
|
US7087592B1
(en)
*
|
1999-08-23 |
2006-08-08 |
Entre Med, Inc. |
Compositions comprising purified 2-methoxyestradiol and methods of producing same
|
|
US6518261B2
(en)
*
|
2000-03-17 |
2003-02-11 |
Oncology Sciences Corporation |
Use of eugenol in combination with other chemopreventative agents as prophylaxis for cancers
|
|
US20050192258A1
(en)
*
|
2000-08-18 |
2005-09-01 |
Agoston Gregory E. |
Antiangiogenic agents
|
|
US6995278B2
(en)
*
|
2000-08-18 |
2006-02-07 |
Entre Med, Inc. |
Antiangiogenic agents
|
|
US7135581B2
(en)
*
|
2000-08-18 |
2006-11-14 |
Entremed, Inc. |
Antiangiogenic agents
|
|
US7691567B2
(en)
|
2000-10-30 |
2010-04-06 |
Board Of Regents, The University Of Texas System |
Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin
|
|
WO2002062348A1
(en)
*
|
2001-02-05 |
2002-08-15 |
Oncology Sciences Corporation |
Eugenol, optionally in combination with 2-methoxyestradiol, as a cancer chemopreventative agent
|
|
EP1373215B1
(en)
*
|
2001-03-30 |
2006-07-26 |
THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH |
Geldanamycin derivatives useful for treating cancer
|
|
WO2003063791A2
(en)
*
|
2002-01-30 |
2003-08-07 |
Entremed, Inc. |
Non-steroidal analogs of 2-methoxyestradiol
|
|
WO2003073985A2
(en)
*
|
2002-03-01 |
2003-09-12 |
Entremed, Inc. |
New methods of using antiangiogenic agents
|
|
EP1490030B2
(en)
*
|
2002-03-20 |
2010-07-14 |
Elan Pharma International Limited |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
DK1530482T3
(da)
|
2002-07-18 |
2014-01-20 |
Helix Biopharma Corp |
Brug af urease til at hæmme vækst af cancerceller
|
|
EP2298315A1
(en)
|
2002-08-28 |
2011-03-23 |
Harbor BioSciences, Inc. |
Therapeutic treatment methods
|
|
MXPA05007382A
(es)
*
|
2003-01-10 |
2005-11-23 |
Threshold Pharmaceuticals Inc |
Tratamiento de cancer con 2-desoxiglucosa.
|
|
US7160908B2
(en)
*
|
2003-03-04 |
2007-01-09 |
Unitech Pharmaceuticals, Inc. |
Dynamic anticancer platinum compounds
|
|
JP2006526025A
(ja)
*
|
2003-05-28 |
2006-11-16 |
エントレメッド インコーポレイテッド |
抗血管新生剤
|
|
US20070004689A1
(en)
*
|
2004-03-12 |
2007-01-04 |
Agoston Gregory E |
Antiangiogenic agents
|
|
US7498322B2
(en)
*
|
2004-03-12 |
2009-03-03 |
Entremed, Inc. |
Antiangiogenic agents
|
|
US20080220069A1
(en)
*
|
2004-09-13 |
2008-09-11 |
Pr Pharmaceuticals, Inc. |
Long Acting Injectable Crystal Formulations of Estradiol Metabolites and Methods of Using Same
|
|
WO2006058298A2
(en)
*
|
2004-11-29 |
2006-06-01 |
Entremed, Inc. |
A method of administering anti-angiogenic agents and a method of treating disease using same
|
|
US20070185069A1
(en)
*
|
2005-11-14 |
2007-08-09 |
Plum Stacy M |
Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents
|
|
US20070176403A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Dennis Calderone |
Air adjustable seat
|
|
WO2007097839A2
(en)
*
|
2006-02-16 |
2007-08-30 |
Massachusetts Eye And Ear Infirmary |
Ansamycin analogs or heat shock 90 inhibitors in combination with pdt treatin conditions of the eye
|
|
WO2007109312A2
(en)
*
|
2006-03-20 |
2007-09-27 |
Entremed, Inc. |
Disease modifying anti-arthritic activity of 2-methoxyestradiol
|
|
US20080234243A1
(en)
*
|
2007-01-31 |
2008-09-25 |
Lavallee Theresa M |
Method of treating amyloidosis mediated diseases
|
|
US9029322B2
(en)
|
2007-06-05 |
2015-05-12 |
Cornell University |
Compounds for enhancing p21 expression and methods of use thereof
|
|
KR20090009637A
(ko)
*
|
2007-07-20 |
2009-01-23 |
삼성전자주식회사 |
엠비-오에프디엠 시스템 및 프레임 바운더리 검출 방법
|
|
CA3001054C
(en)
*
|
2015-10-08 |
2021-12-14 |
University Of Utah Research Foundation |
Elephant p53 proteins and nuleic acids encoding the same for preventing or treating cancer
|
|
KR101837735B1
(ko)
*
|
2016-08-08 |
2018-04-19 |
성균관대학교산학협력단 |
TCTP (Translationally controlled tumour protein) 단백질을 포함하는 난모세포(oocytes) 노화 방지 또는 수정능력 개선용 조성물
|